Extracellular Vesicle Protein Panel Enables Early Lung Cancer Detection in a Large Clinical Cohort
Journal of Extracellular Vesicles · 2025-08 · 14 (8)
DOI: 10.1002/jev2.70129 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 06.08.2025. Verfasst von Linxiao Han und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Shanghai Respiratory Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Early Detection of Cancer, Extracellular Vesicles, Lung Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Shanghai Municipal Science and Technology Major Project.
Abstract (Originalsprache)
The early detection and diagnosis of lung cancer through extracellular vesicle (EV)‐based liquid biopsy show substantial promise for enhancing clinical outcomes. Nonetheless, there is a scarcity of large‐scale clinical investigations validating EV‐based liquid biopsy. To evaluate the EV membrane protein panel as a diagnostic tool for early‐stage cancer detection and validate its efficacy and clinical applicability, a cohort comprised of 302 individuals without cancer and 645 with lung cancer was recruited. Participants were randomly divided into training and validation cohorts at a 1:1 ratio while maintaining the proportion of different subtypes. A diagnostic panel (EV early lung cancer membrane protein 5, EV ELC‐M5 ) consisting of five EV membrane proteins (CD81, PDL1, GLIPR1, LBR and SFTPA1) was developed using a High‐throughput Nano‐biochip Integrated System for Liquid Biopsy (HNCIB) to realize rapid analysis of a large cohort of patient samples at a single EV level. EV ELC‐M5 could accurately differentiate patients with early lung cancer from the control group. The area under the curve (AUC) of EV ELC‐M5 for distinguishing patients with early lung cancer from the control group in the validation cohort was 0.926, and the AUC for diagnosing patients with early lung cancer with lung nodules ≤ 8 mm was 0.931. EV‐SFTPA1 proved to be the most effective marker, exhibiting a sensitivity of 89.4% in patients with early lung cancer. To our knowledge, this is the first study to use EV‐SFTPA1 for early lung cancer detection, elucidating its robust tissue specificity. Collectively, the findings highlight that EV ELC‐M5 in conjunction with HNCIB is an effective diagnostic toolset for detecting early lung cancer and substantially promotes its diagnosis. Trial Registration : ClinicalTrials.gov identifier: ChiCTR2300072317
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Shanghai Respiratory Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
- Shanghai Engineering Research Center of Internet of Things for Respiratory Medicine, Shanghai, China.
- Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, China.
- Center of Emergency and Critical Medicine in Jinshan Hospital of Fudan University, Fudan University, Shanghai, China.
- Department of Respiratory Endoscopy, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
- Department of Respiratory and Critical Care Medicine, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
ORCID-Profile: Jian Zhou
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Shanghai Municipal Science and Technology Major Project
- Shanghai Municipal Key Clinical Specialty
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Han, L., Song, Y., Tong, L., Sun, J., Zhang, X., Chen, S., Li, Y., Wang, Z., Gao, L., Zhu, Q., Chao, Y., Wang, X., Zhang, G., Zhu, W., He, L., Liu, J., Wang, Q., Wu, Z., Ji, Y., …, & Zhou, J. (2025). Extracellular Vesicle Protein Panel Enables Early Lung Cancer Detection in a Large Clinical Cohort. Journal of Extracellular Vesicles, 14(8). https://doi.org/10.1002/jev2.70129
Vancouver
Han L, Song Y, Tong L, Sun J, Zhang X, Chen S, et al. Extracellular Vesicle Protein Panel Enables Early Lung Cancer Detection in a Large Clinical Cohort. Journal of Extracellular Vesicles. 2025;14(8). doi:10.1002/jev2.70129
BibTeX
@article{Han2025,
author = {Han, Linxiao and Song, Yuanlin and Tong, Lin and Sun, Jiayuan and Zhang, Xiaoju and Chen, Shujing and Li, Ying and Wang, Ziqi and Gao, Lei and Zhu, Qiaoliang and Chao, Yencheng and Wang, Xiaocen and Zhang, Ge and Zhu, Wensi and He, Ludan and Liu, Jie and Wang, Qin and Wu, Zuoren and Ji, Yuanyuan and Bai, Chunxue and Lv, Xiuzhen and Zhou, Jian},
title = {Extracellular Vesicle Protein Panel Enables Early Lung Cancer Detection in a Large Clinical Cohort},
journal = {Journal of Extracellular Vesicles},
year = {2025},
volume = {14},
number = {8},
doi = {10.1002/jev2.70129}
}
EUVIMED